Nonmydriatic imaging useful in diabetic children

Article

Ophthalmologists may use nonmydriatic retinal imaging to supplement the standard clinical exam to screen diabetic children aged as young as 2 years, according to newly published research.

Ophthalmologists may use nonmydriatic retinal imaging to supplement the standard clinical exam to screen diabetic children aged as young as 2 years, according to newly published research.

US researchers conducted a prospective study of 106 children with type 1 diabetes who were aged 2 to 17 years. The study included an intake form; blood pressure, pulse and oximetry measurements; visual acuity assessment (Simav, Padova) and nonmydriatic colour imaging (CX-1 45° 15.1 megapixel camera, Canon). They assessed images for indications of diabetic retinopathy, and two clinicians graded image quality on a scale of 1 to 5.

Ninety-eight percent of the children underwent imaging. One was found to have nonproliferative diabetic retinopathy, and findings for 2 were incidental.

Sixty-two percent of the children had had an eye exam within the past year, with exams significantly more likely among older children and those who had had type 1 diabetes for more than 5 years.

Investigators graded images as high quality in 178 (86%) eyes, and they said images of some clinical value were obtained in 207 (99.5%) eyes.

The researchers shared their results in the Journal of Pediatric Ophthalmology and Strabismus.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.